Evidence map›Paper›PMID 32275452›Full record

ArticleAmerican journal of respiratory and critical care medicine2020

COVID-19 with Different Severities: A Multicenter Study of Clinical Features.

Yun Feng, Yun Ling, Tao Bai, Yusang Xie, Jie Huang, Jian Li, Weining Xiong, Dexiang Yang, Rong Chen, Fangying Lu and 11 more

2 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 520 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
520citing papers in PubMed, 16 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04466670 phase2unknown statusnot on this map

Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2020 to 2022Enrolled379ConditionsCOVID-19Armsacetylsalicylic acid, Unfractionated heparin nebulized
NCT04896866 nacompletednot on this mapstarted 2021, after this paper: background citation

Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients: A Pragmatic Clinical Trial

TypeinterventionalSponsorUniversity of AlbertaRan2021 to 2021Enrolled833ConditionsCovid19, COVID-19 Pneumonia, COVID-19 Lower Respiratory Infection, COVID-19 Acute Respiratory Distress SyndromeArmsAntimicrobial stewardship prospective audit and feedback
3 · Its place in the literature

Who cites it

520 citing papers in PubMed, 16 syntheses or guidelines pooled it, 890 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Trial
  20. Trial

460 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Yun FengDepartment of Respiratory and Critical Care Medicine.ORCID 0000-0001-8198-5240
Yun LingDepartment of Infectious Disease.ORCID 0000-0002-4289-3594
Tao BaiDepartment of Infectious Disease, Wuhan Jinyintan Hospital, Wuhan, China.
Yusang XieDepartment of Respiratory and Critical Care Medicine.ORCID 0000-0002-6612-3930
Jie HuangDepartment of Critical Medicine, and.
Jian LiClinical Research Center, Ruijin Hospital.
Weining XiongDepartment of Respiratory and Critical Care Medicine, The Ninth People's Hospital.
Dexiang YangDepartment of Respiratory Diseases, Tongling People's Hospital, Anhui, China.
Rong ChenDepartment of Respiratory and Critical Care Medicine.
Fangying LuDepartment of Respiratory and Critical Care Medicine.
Yunfei LuDepartment of Traditional Chinese Medicine, and.
Xuhui LiuRespiratory and Tuberculosis Department, Shanghai Public Health Clinical Center, Shanghai, China.ORCID 0000-0002-6460-6787
Yuqing ChenDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, and.
Xin LiCardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; and.
Yong LiDepartment of Respiratory and Critical Care Medicine, Ruijin North Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hanssa Dwarka SummahChest Department, Poudre d'Or Chest Hospital, Riviere du Rempart, Mauritius.
Huihuang LinDepartment of Respiratory and Critical Care Medicine.
Jiayang YanDepartment of Respiratory and Critical Care Medicine.
Min ZhouDepartment of Respiratory and Critical Care Medicine.ORCID 0000-0002-8718-8506
Hongzhou LuDepartment of Infectious Disease.ORCID 0000-0002-8308-5534
Jieming QuDepartment of Respiratory and Critical Care Medicine.ORCID 0000-0003-4517-9473
Chest Diseases Hospital · KWJinyintan Hospital · CNRuijin Hospital · CNShanghai Chest Hospital · CNShanghai Jiao Tong University · CNShanghai Public Health Clinical Center · CNSoochow University · CNSun Yat-sen University · CNThe People's Hospital Tongling · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAge FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsBetacoronavirusChinaComorbidityCoronavirus InfectionsCOVID-19Critical IllnessFemaleHospital MortalityHumansIncidenceLungAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsACEI/ARBCOVID-19multiple lung lobe involvementpleural effusionseverity

Identifiers

PMID32275452
PMCPMC7258639
OpenAlexW3015407900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.